LCZ696, Angiotensin II Receptor-Neprilysin Inhibitor, Ameliorates High-Salt-Induced Hypertension and Cardiovascular Injury More Than Valsartan Alone.

American Journal of Hypertension
Hiroaki KusakaShokei Kim-Mitsuyama

Abstract

LCZ696, an angiotensin receptor-neprilysin inhibitor, has recently been demonstrated to exert more beneficial effects on hypertensive or heart failure patients than conventional renin-angiotensin system blockers. However, the mechanism underlying the benefit of LCZ696 remains to be understood. The present study was undertaken to examine the effect of LCZ696 compared with valsartan on hypertension and cardiovascular injury. (i) Using telemetry, we compared the hypotensive effect of LCZ696 and valsartan in spontaneously hypertensive rats (SHR) that were fed a high-salt diet followed by a low-salt diet. (ii) We also examined the comparative effect of LCZ696 and valsartan on salt loaded SHRcp, a model of metabolic syndrome. (i) LCZ696 exerted a greater blood pressure (BP) lowering effect than valsartan in SHR regardless of high-salt or low-salt intake. Additive BP reduction by LCZ696 was associated with a significant increase in urinary sodium excretion and sympathetic activity suppression. (ii) LCZ696 significantly ameliorated cardiac hypertrophy and inflammation, coronary arterial remodeling, and vascular endothelial dysfunction in high-salt loaded SHRcp compared with valsartan. LCZ696 caused greater BP reduction than valsartan i...Continue Reading

References

Jul 31, 1998·The New England Journal of Medicine·E R LevinW K Samson
Mar 8, 2003·Hypertension·Duncan John Campbell
May 25, 2005·Peptides·Kailash N Pandey
Aug 31, 2012·Lancet·Scott D SolomonUNKNOWN Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investig
Jul 23, 2013·Clinical Pharmacology and Therapeutics·O VardenyS D Solomon
Sep 2, 2014·The New England Journal of Medicine·John J V McMurrayUNKNOWN PARADIGM-HF Investigators and Committees

❮ Previous
Next ❯

Citations

Aug 20, 2015·American Journal of Hypertension·Jose C Peña, Luis M Ruilope
Jun 24, 2015·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·M VolpeS Rubattu
Jul 28, 2016·Pharmacology & Therapeutics·Achim Lother, Lutz Hein
Dec 16, 2016·Nature Reviews. Cardiology·Duncan J Campbell
Apr 8, 2017·Expert Opinion on Investigational Drugs·Guillermo Gervasini, Nicolas Roberto Robles
Apr 28, 2018·Current Opinion in Cardiology·Merrill H StewartHector O Ventura
May 1, 2019·International Journal of Molecular Sciences·Massimo VolpeAllegra Battistoni
Nov 20, 2016·Cardiovascular Drugs and Therapy·L M LinJ X Lin
Nov 30, 2018·JAMA Cardiology·Kelsie E OatmenFrancis G Spinale
May 12, 2019·British Journal of Pharmacology·Vyacheslav A KorshunovBradford C Berk
Feb 20, 2019·International Journal of Molecular Sciences·Speranza RubattuMassimo Volpe
Nov 11, 2018·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Amanda J Miller, Amy C Arnold
Nov 6, 2020·Current Opinion in Nephrology and Hypertension·Parminder K Judge, Richard Haynes
Feb 2, 2021·Frontiers in Pharmacology·Wenchao ZhangYi-Fei Dong
Aug 1, 2018·JACC. Basic to Translational Science·Masanobu IshiiKenichi Tsujita
Jun 30, 2021·Autonomic Neuroscience : Basic & Clinical·Kanokwan BunsawatD Walter Wray

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.